Abbvie has been falling hard on news that it will sell off some drug patents in order to win approval for its merger with Allergan. It is entering a support zone between about $77 and $81, however, and it may start to climb from here as investors start to get excited about the merger. Also look for Coronavirus news to move the stock; word on the street is that one...
I reevaluated the falling wedge and it occurred to me. This was was a failed wedge that created a new falling wedge ( Note Dark Gray lines vs. White lines). Here are my latest notes: -The Last 2 days have show a strong support around $ 0.77 which is also the 50 day MA. -Stochastic: Showing a strong Divergence as well as being oversold. -On Balance Volume: Still...
ISEE broke out from a long-time base with tremendous volume. It pulled back and built a small base. At the time, although it may be not the best win-lose position, it has the best risk-reward.
4hr chart is still clean on the falling wedge. Just like many one day dips in the market this could rocket back hard tomorrow!! Buy buy buy
Perfect close yesterday to bounce off support into a major move up! This is what we have been waiting for! Notes: -Stochastic: is sitting in a good spot: Neutral ( Not oversold or Over bought) -On Balance Volume: Still trending up on the daily very strong sign, especially with the price decline in the short term, The OBV hints at strong momentum still. -Falling...
The daily chart Still playing out a much larger Falling wedge, Still Bullish! If we close above $1.01 ( right at the 20 MA) we are still if a great place! Better discount buy opportunities right now! Remember Sometimes you have to go down a little for a large jump!!! Literally think about jumping off the ground.... you bend your knees get really low and then leap...
As long as my line stay green adding on dip this week is an opportunity to profit early in Spring ( seeded time for #biotech is now) but mostly trading on daily base , today I wait longer 3-4 days perhaps
PCI Biotech: US patent granted for the vaccine technology (fimaVACC) in combination with cytokines Oslo (Norway), 21 January 2020 – PCI Biotech OSL:PCIB , a cancer focused biopharmaceutical company, today announces that the U.S. Patent and Trademark Office (USPTO) has granted the company a US patent covering the use of fimaVacc in combination with...
Friday's session presented a retracement on the 20 EMA Line, as predicted. I still believe in the continuation of the bullish trend. However, the bearish divergence needs to be monitored, since further price correction could occur. Disclosure: My ideas contain statements and projections based on assumptions on capital markets, and therefore inherently subject to...
Technical RSI, MACD and momentum indicator (Lazybear) and chart looks like Moderna will be falling this week (8% +/- 5%) I plan to accumulate on dips into the $19 area while looking at charts. To confirm the formation of reverse head and shoulders, the nice symmetrical MACD and momentum swings with RSI reaching a bottom would confirm MRNA is poised to break...
The 9 EMA should be a nice bounce point. Watch the Stochastic, needs to cool off a little bit before we Take off!!
The data is positive, but seems like an overreaction for a small and early stage trial. Watching the chart and will enter a short in the future, at what level is difficult to say. I like the gaps down, however it is more likely to bleed lower versus dramatically dropping. XBI is nearing all time highs, this is a high beta stock, so the correlation will not be great.
Today's session generated a bearish divergence on CCI. I am still bullish, but always ready for a trend retracement on the 20 EMA Line. Disclosure: My ideas contain statements and projections based on assumptions on capital markets, and therefore inherently subject to numerous risks and uncertainties. Before buying or selling any stock you should do your own...
Ichimoku Clouds still confirm the bullish setup. Today's session will be important, if positive, to manifest further bullish intentions (Break of the $92.10 resistance). Disclosure: My ideas contain statements and projections based on assumptions on capital markets, and therefore inherently subject to numerous risks and uncertainties. Before buying or selling...
If you like this idea, don't forget to support it clicking the Like Button! Positive session for Nasdaq Healthcare that gained 0.39%. However, I still see the possibility of a retracement over the basis of the Bollinger Bands indicator (orange crosses). I was waiting with anxiety today's session to check for a signal of retracement, and it comes with the third...
ZFGN has been showing the cup and handle pattern on its daily chart. With the shape of a flat "U" and a slight down drifted-handle on the right, ZFGN is considered a sign of bullish continuation. The length of its "U" period indicates the bottom has been consolidated and the risk has been shaken out. Volume remained lower than average in the base of the bowl,...
Nektar and Bristol-Myers Squibb announced today the companies have agreed to a new joint development plan to advance bempegaldesleukin (bempeg) plus Opdivo (nivolumab) into multiple new registrational trials (source: Yahoo Finance). The 19% jump is making Nektar trading around its fair value. Likely, profit-taking will take place in the next sessions. I'm...
Good session for the Nasdaq Healthcare Index, that closed the day with a 1.30% gain. Bullish sentiment is still driving trades. However next session could be characterized by a retracement around the basis of the Bollinger Bands indicator (orange crosses). This is a daily analysis. Disclosure: My ideas contain statements and projections based on assumptions on...